Kids_First_Participant_ID	gene_symbol	pathology_diagnosis	pathology_free_text_diagnosis	MYCN_CN	MYCN_CN_status	Kids_First_Biospecimen_ID_DNA	match_id	sample_id	aliquot_id	cohort	Kids_First_Biospecimen_ID_RNA	MYCN_TPM
PAUIJR	MYCN	Neuroblastoma	MYCN non-amp	3	gain	BS_00PH2T1P	PAUIJR_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_P10Y42BX	13.05
PASMIU	MYCN	Neuroblastoma	MYCN non-amp	3	gain	BS_0RBGK29M	PASMIU_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_KC02E200	48.41
PAVHWG	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_0T5A16N2	PAVHWG_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_KHW6ASK4	17.78
PAVFAP	MYCN	Neuroblastoma	MYCN non-amp	3	loss	BS_0TER803R	PAVFAP_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_ZGKT8MMX	24.21
PARZCJ	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_1G3QX306	PARZCJ_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_FHNTKFVJ	14.28
PARZCJ	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_1G3QX306	PARZCJ_01_Solid Tissue_Primary Tumor	01	01A	GMKF	TARGET-30-PARZCJ-01A-01R	29.97
PARYEH	MYCN	Neuroblastoma	MYCN non-amp	3	loss	BS_1G5N5R8S	PARYEH_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_2Y28PRQC	22.31
PAUIRD	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_20HSXMYQ	PAUIRD_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_02X4QTNE	27.44
PATSTU	NA	Ganglioneuroblastoma, nodular	MYCN non-amp	NA	NA	BS_255803B6	PATSTU_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_3D1XTG0K	4.33
PATWPC	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_25EXB29C	PATWPC_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_8V59CEJJ	10.85
PT_W7FK539G	MYCN	Neuroblastoma	Metastatic secondary tumors;Neuroblastoma	4	gain	BS_25VZM81R	PT_W7FK539G_7316-76_Solid Tissue_Progressive	7316-76	588045	PBTA	BS_XBQZYS8G	425.63
PARXPD	MYCN	Neuroblastoma	MYCN non-amp	3	loss	BS_29DZNQYC	PARXPD_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_3N0ZS3G3	24.86
PARYAG	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_29MQMSCM	PARYAG_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_YZJ5YQ12	1.84
PAUPNR	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_2ABKFT99	PAUPNR_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_QCDCAX7G	21.78
PASXIE	MYCN	Neuroblastoma	MYCN amp	6	gain	BS_2N95EW0G	PASXIE_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_9TKGBJH7	548.93
PASXIE	MYCN	Neuroblastoma	MYCN amp	6	gain	BS_2N95EW0G	PASXIE_01_Solid Tissue_Primary Tumor	01	01A	GMKF	TARGET-30-PASXIE-01A-01R	1258.74
PAVBLT	MYCN	Neuroblastoma	MYCN non-amp	3	gain	BS_2NPW3A08	PAVBLT_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_PRF6XPXV	15.15
PATGLU	MYCN	Neuroblastoma	MYCN non-amp	3	gain	BS_2P6MH05V	PATGLU_01_Solid Tissue_Primary Tumor	01	01A	GMKF	TARGET-30-PATGLU-01A-01R	50.36
PAUKLK	MYCN	Neuroblastoma	MYCN amp	125	amplification	BS_2R0QBATZ	PAUKLK_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_94JMQ7MX	296.15
PASVXS	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_2SFR8Z1P	PASVXS_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_8T0AKNMJ	9.01
PASFKX	MYCN	Neuroblastoma	MYCN amp	3	loss	BS_2X9EVKZ0	PASFKX_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_6N7RPHX9	392.43
PASIIB	MYCN	Neuroblastoma	MYCN non-amp	3	gain	BS_30NT6PNA	PASIIB_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_6GSJCDCN	13.32
PASNUI	MYCN	Neuroblastoma	MYCN amp	647	amplification	BS_3564XTTK	PASNUI_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_3CSY3JTN	407.97
PATLBP	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_38SSRZJ1	PATLBP_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_Y2DSNJ1E	14.18
PATLFX	MYCN	Neuroblastoma	MYCN non-amp	3	gain	BS_3AKS23A0	PATLFX_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_F2F7BXT5	26.59
PAVIZV	MYCN	Ganglioneuroblastoma, nodular	MYCN non-amp	3	gain	BS_3KPKZVGX	PAVIZV_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_ZKQXXTG9	10.07
PAVIAZ	NA	Ganglioneuroblastoma, nodular	MYCN non-amp	NA	NA	BS_4GHFYCWZ	PAVIAZ_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_QM9CBE54	1.41
PAUJEJ	MYCN	Neuroblastoma	MYCN non-amp	5	amplification	BS_4J8JK335	PAUJEJ_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_H4TFY19Z	111.17
PT_DFCZAG9T	MYCN	Neuroblastoma	neuroblastoma, metastatic	100	amplification	BS_4NPEMNAD	PT_DFCZAG9T_7316-224_Solid Tissue_Initial CNS Tumor	7316-224	588042	PBTA	BS_DY88N5ZT	93.25
PARTRP	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_4RX1AAVV	PARTRP_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_S0B4WASX	16.43
PATLSY	NA	Ganglioneuroblastoma, nodular	MYCN non-amp	NA	NA	BS_4VKRBRJC	PATLSY_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_F9ZXCH60	3.7
PAULDT	MYCN	Neuroblastoma	MYCN non-amp	3	neutral	BS_5ACNB1BG	PAULDT_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_CN3256VE	27.11
PAUPWN	MYCN	Neuroblastoma	MYCN non-amp	3	gain	BS_5BB8J64W	PAUPWN_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_T7MWWC0A	28.78
PASFWL	MYCN	Neuroblastoma	MYCN non-amp	3	loss	BS_5BFNH9S6	PASFWL_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_WHX83JW2	34.59
PAUUWG	NA	Ganglioneuroblastoma, intermixed	MYCN non-amp	NA	NA	BS_5CR48ZM7	PAUUWG_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_TGDZ491N	0.83
PAUJTY	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_5DXK26YF	PAUJTY_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_X3F8NMS4	14.62
PT_FZHGKJ0H	NA	Ganglioneuroblastoma	ganglioneuroblastoma, stage ii favorable histology non n-myc amplified	NA	NA	BS_5J5VH3X0	PT_FZHGKJ0H_7316-4034_Solid Tissue_Initial CNS Tumor	7316-4034	725405	PBTA	BS_2SHWPB5P	0.18
PAUPMU	NA	Ganglioneuroblastoma, intermixed	MYCN non-amp	NA	NA	BS_5QFRPR61	PAUPMU_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_FC37XAZK	3.07
PATFIK	MYCN	Neuroblastoma	MYCN non-amp	3	gain	BS_64P50TAP	PATFIK_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_CZMY8CVE	41.21
PT_RXT6KRR6	NA	Ganglioneuroblastoma	ganglioneuroblastoma, who grade iv	NA	NA	BS_68BZ8N6P	PT_RXT6KRR6_7316-3168_Solid Tissue_Recurrence	7316-3168	1228848	PBTA	BS_NGAWSN7T	8.48
PASMUB	MYCN	Neuroblastoma	MYCN non-amp	3	gain	BS_69KVWAWK	PASMUB_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_H5RWQDCJ	10.97
PATVKN	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_6AENZKKA	PATVKN_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_Z36F6GKX	11.39
PATNXK	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_6FA0NNF1	PATNXK_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_S0SM38BZ	23.59
PASLIH	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_6KH6CXMH	PASLIH_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_HW9CGZ29	20.29
PATXTF	MYCN	Neuroblastoma	MYCN non-amp	5	gain	BS_76SQJSHP	PATXTF_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_BW9QBKEQ	36.56
PAVINE	MYCN	Neuroblastoma	MYCN non-amp	3	gain	BS_7BJQNVK8	PAVINE_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_EMBK3HHP	19.52
PATWPL	MYCN	Neuroblastoma	MYCN non-amp	3	neutral	BS_7HRQNWJY	PATWPL_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_STTGK8V4	34.48
PASAGA	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_7MXT22QP	PASAGA_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_9R8GFR36	11.82
PATBGF	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_7W42FH5A	PATBGF_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_M462FWS9	6.68
PARUZA	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_808H2FQN	PARUZA_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_ERHKS2Y7	0.49
PAVNLK	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_87J6X9KJ	PAVNLK_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_135GYQQD	27.75
PAUXGR	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_8MJNDM75	PAUXGR_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_MBNSCVMH	6.93
PASSWW	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_8S0EDFTP	PASSWW_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_K9VNW7JD	9.37
PASSWW	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_8S0EDFTP	PASSWW_01_Solid Tissue_Primary Tumor	01	01A	GMKF	TARGET-30-PASSWW-01A-01R	17.69
PARYRJ	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_92YFTG9R	PARYRJ_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_JY850J9G	26.4
PAVKRF	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_95PV1RRY	PAVKRF_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_SZ3EJPGV	12.8
PAUNTY	NA	Neuroblastoma	MYCN amp	NA	NA	BS_9BZBCZHK	PAUNTY_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_VNKT3ZZS	312.62
PASUMK	NA	Ganglioneuroma, maturing subtype OR Ganglioneuroblastoma, well differentiated	MYCN non-amp	NA	NA	BS_9CPZ5R1T	PASUMK_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_RW0JJ9BQ	0.6
PASUEZ	MYCN	Neuroblastoma	MYCN non-amp	3	neutral	BS_9ND96NYZ	PASUEZ_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_MDEQHB6J	33.28
PATPFG	MYCN	Neuroblastoma	MYCN non-amp	3	gain	BS_9PEJSEZG	PATPFG_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_AYDD070S	22.7
PASUVU	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_9PRG9CJC	PASUVU_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_MGHRCZEV	24.63
PASXSJ	MYCN	Neuroblastoma	MYCN amp	106	amplification	BS_9ZDR2H7D	PASXSJ_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_XZQE9FBM	261.14
PATZRF	MYCN	Neuroblastoma	MYCN amp	18	amplification	BS_A527Y2QF	PATZRF_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_S4WH99C9	235.02
PATLKI	MYCN	Ganglioneuroblastoma, nodular	MYCN amp	3	gain	BS_A5AQFAFA	PATLKI_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_QJ3XB7XZ	29.28
PASPGB	MYCN	Neuroblastoma	MYCN amp	3	gain	BS_ACCE0MEA	PASPGB_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_94ZKC2SR	273.35
PATSUL	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_ACDQRWMY	PATSUL_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_MG1N76FY	8.57
PASLTC	MYCN	Neuroblastoma	MYCN non-amp	3	gain	BS_AE718N55	PASLTC_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_ZWRZRC4V	48.71
PASWEE	MYCN	Neuroblastoma	MYCN non-amp	3	gain	BS_APY3G22J	PASWEE_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_A70FPYSH	32.65
PATTHB	MYCN	Neuroblastoma	MYCN non-amp	3	gain	BS_B2RYV4GG	PATTHB_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_S32M2YTY	25.6
PASDYT	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_B6E0477K	PASDYT_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_N13KZYRR	17.46
PAUSJB	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_BJCTR4C8	PAUSJB_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_GB1XPW06	8.68
PATMDE	NA	Ganglioneuroblastoma, intermixed	MYCN non-amp	NA	NA	BS_BPXHZ3Y0	PATMDE_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_5W25GMQ1	2.09
PAULZB	MYCN	Neuroblastoma	MYCN non-amp	3	gain	BS_BTRGQHM4	PAULZB_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_HHNQ3N2V	23.37
PAUYFR	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_BVAVPKKN	PAUYFR_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_5Y98E084	11.97
PASTWY	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_C3KT9THS	PASTWY_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_8EX2H96N	42.87
PARWEV	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_C8T56CWR	PARWEV_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_DBXCETW2	33.86
PASSMV	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_C9YD10Y4	PASSMV_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_EXEE6TDK	7.74
PASRRY	MYCN	Neuroblastoma	MYCN non-amp	3	gain	BS_CD6KRB1K	PASRRY_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_GWN2F333	25.98
PT_RXT6KRR6	MYCN	Ganglioneuroblastoma	ganglioneuroblastoma	3	gain	BS_CK7CPM73	PT_RXT6KRR6_7316-3147_Solid Tissue_Recurrence	7316-3147	725396	PBTA	BS_NFRXNAFE	4.68
PASKZT	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_CKVK1AYV	PASKZT_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_CZ7DWCPE	2.05
PAUYJS	MYCN	Neuroblastoma	MYCN non-amp	4	gain	BS_CWPHVM94	PAUYJS_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_48YZKWC2	32.85
PASJTA	MYCN	Neuroblastoma	MYCN non-amp	3	gain	BS_DFJYRYV1	PASJTA_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_WHBM0N3Y	19.87
PASZTC	MYCN	Neuroblastoma	MYCN non-amp	3	gain	BS_DGV11G69	PASZTC_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_RZEEJETF	19.89
PASCWD	MYCN	Neuroblastoma	MYCN amp	132	amplification	BS_DWYR5CTE	PASCWD_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_W5X4568N	310.39
PATDCJ	MYCN	Neuroblastoma	MYCN non-amp	3	gain	BS_DZ998H9P	PATDCJ_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_BBD7XS5N	13.3
PATUBI	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_E4N511ZX	PATUBI_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_E359X3QV	26.85
PAUNZM	MYCN	Neuroblastoma	NA	3	gain	BS_E9YW2KHS	PAUNZM_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_VR7XMQZ3	26.7
PATVHJ	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_EDGSP4V6	PATVHJ_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_8GD69HHF	16.33
PT_EB0D3BXG	NA	Neuroblastoma	Metastatic secondary tumors;Neuroblastoma	NA	NA	BS_F0GNWEJJ	PT_EB0D3BXG_7316-3311_Solid Tissue_Progressive	7316-3311	711411	PBTA	BS_VNWKNRY4	7.83
PARZBH	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_F6MNG2S0	PARZBH_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_BG0ZDND2	22.7
PATCVK	NA	Ganglioneuroblastoma, intermixed	MYCN non-amp	NA	NA	BS_F92J3KBA	PATCVK_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_JWXQFZY9	15.78
PASUCU	MYCN	Neuroblastoma	MYCN non-amp	3	gain	BS_FAEHNS3Q	PASUCU_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_4JVC08W2	26.41
PAUJRW	MYCN	Neuroblastoma	MYCN amp	3	gain	BS_FJP95JXF	PAUJRW_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_ZFJS669M	352.32
PAUCIK	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_FR9R7VFY	PAUCIK_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_YMWFA93F	12.05
PATSNC	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_FXG6F3NN	PATSNC_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_WKC3GR0D	8.33
PATTNX	MYCN	Neuroblastoma	MYCN non-amp	3	gain	BS_G4W213NW	PATTNX_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_DHXNWXP6	36.26
PATNXJ	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_GAA781GQ	PATNXJ_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_MH01GQ2B	28.29
PATTPC	MYCN	Neuroblastoma	MYCN amp	244	amplification	BS_GBS4JMAZ	PATTPC_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_NKGRBE18	393.89
PATIIT	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_GFN4FETJ	PATIIT_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_2480EHNY	42.43
PAVINT	MYCN	Neuroblastoma	MYCN non-amp	3	loss	BS_GNETMRJF	PAVINT_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_KG9X0NFD	8.91
PAVALS	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_H0MVFRCE	PAVALS_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_NZDEF29S	30.63
PATBFN	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_HCWEF4QN	PATBFN_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_Z3BZ01S1	33.83
PAUAEE	MYCN	Neuroblastoma	MYCN non-amp	3	loss	BS_HQC1EKZ8	PAUAEE_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_0JBZPAGN	31.89
PASCGM	MYCN	Neuroblastoma	MYCN non-amp	3	neutral	BS_HYX0M8VM	PASCGM_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_REGK1PS6	5.56
PATWED	MYCN	Neuroblastoma	MYCN amp	29	amplification	BS_HZKJMB0D	PATWED_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_YA56YE71	82.09
PASAVJ	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_J3707KE2	PASAVJ_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_28ZRHXX8	21.16
PAVFNX	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_J6FPW4H0	PAVFNX_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_FJAQ3KAX	28.13
PASBDN	MYCN	Neuroblastoma	MYCN non-amp	3	gain	BS_JGVTE14P	PASBDN_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_15ED4VDX	31.15
PASKFM	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_JQ0XD1K9	PASKFM_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_EE5Z0Z4J	50.58
PAUWBU	MYCN	Neuroblastoma	MYCN non-amp	3	gain	BS_JTP91S1A	PAUWBU_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_2RFA5NWH	24.9
PAVGYW	MYCN	Neuroblastoma	MYCN non-amp	3	gain	BS_JV1GTZ1Q	PAVGYW_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_82Q78622	32.44
PATJDG	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_JZFMHGNX	PATJDG_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_ETC8R0TD	1.7
PARUTJ	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_K2K5YSDS	PARUTJ_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_S5KDWVEA	0.41
PATETW	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_K5DHTP34	PATETW_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_3GRJH3PS	17.35
PATSRY	MYCN	Neuroblastoma	MYCN non-amp	3	loss	BS_K62HBS01	PATSRY_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_WFCVBVDS	29.52
PASFEU	NA	Ganglioneuroblastoma, intermixed	MYCN non-amp	NA	NA	BS_KE5D12KG	PASFEU_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_W3ZSVEVP	1.62
PT_5SX0GRW1	MYCN	Neuroblastoma	Metastatic secondary tumors;Neuroblastoma	4	gain	BS_KP0YNTAK	PT_5SX0GRW1_7316-1927_Solid Tissue_Deceased	7316-1927	573071	PBTA	BS_1RT76ANT	11.88
PAUCNL	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_KTHF096D	PAUCNL_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_HEJAPS03	22.84
PAUVPT	NA	Ganglioneuroblastoma, nodular	MYCN non-amp	NA	NA	BS_M7D3Q30Z	PAUVPT_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_XME1VS17	9.42
PASFEV	MYCN	Neuroblastoma	MYCN non-amp	3	neutral	BS_MCCJ3EMF	PASFEV_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_Z0MTZA9K	32.76
PASMGS	MYCN	Neuroblastoma	MYCN non-amp	3	loss	BS_MJ2H7ZT3	PASMGS_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_59ZF7365	28.29
PAURJG	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_MMBWD5VD	PAURJG_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_KF4AR0FG	25.32
PAVHGP	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_MW0JYGG1	PAVHGP_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_6DXDS5EE	22.71
PT_FZHGKJ0H	NA	Ganglioneuroblastoma	ganglioneuroblastoma, stage ii favorable histology non n-myc amplified	NA	NA	BS_NHMPQ8Q1	PT_FZHGKJ0H_7316-4033_Solid Tissue_Initial CNS Tumor	7316-4033	725404	PBTA	BS_JBGZ7HHZ	0.02
PATNUK	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_NK1FJNRG	PATNUK_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_XHSRBERM	11.42
PATUPN	NA	Ganglioneuroblastoma, nodular	MYCN non-amp	NA	NA	BS_NNH2A86D	PATUPN_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_10MQQC5C	13.36
PT_QHJSYTWJ	NA	Neuroblastoma	neuroblastoma (schwannian stroma poor),	NA	NA	BS_NQ41MEBX	PT_QHJSYTWJ_7316-8120_Not Available_Initial CNS Tumor	7316-8120	7316-8120_DGD_COMPT_53	DGD	BS_XBQDMMB3	NA
PAUGVZ	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_NQN1P6QY	PAUGVZ_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_J9EH31NM	15.43
PAUKYI	NA	Ganglioneuroblastoma, nodular	MYCN non-amp	NA	NA	BS_NV00B2Y5	PAUKYI_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_63ACHY8K	1.68
PAUHXD	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_NV9ZB445	PAUHXD_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_VV8GRGZ6	22.9
PASNHY	MYCN	Neuroblastoma	MYCN non-amp	3	gain	BS_NVJJJ7MT	PASNHY_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_WKPG4MH1	41.56
PAVCLX	MYCN	Neuroblastoma	MYCN non-amp	3	loss	BS_NX91DYXQ	PAVCLX_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_MEN59ZX5	45.57
PAUMJN	MYCN	Neuroblastoma	MYCN amp	59	amplification	BS_P0BHM8S1	PAUMJN_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_CCV91DR0	66.35
PAVLFB	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_P5VHEN5Q	PAVLFB_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_R232Y3SW	48.11
PAUCRL	NA	Ganglioneuroblastoma, nodular	MYCN non-amp	NA	NA	BS_PGBR1H2A	PAUCRL_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_SM1QE9FJ	10.42
PATAAV	MYCN	Neuroblastoma	MYCN non-amp	3	gain	BS_PKHXM1NB	PATAAV_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_XJDB3R9K	8.73
PAVBLZ	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_PNF2SHN9	PAVBLZ_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_8EG9GQZS	26.37
PASFCG	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_PQFKEKEW	PASFCG_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_WR5VE59B	24.8
PASTZR	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_PS8TB6Z0	PASTZR_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_HA1N9VCX	23.06
PASREY	MYCN	Neuroblastoma	MYCN non-amp	3	neutral	BS_QCP0VAZ7	PASREY_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_6Y5F3QGV	11.05
PASVYV	MYCN	Neuroblastoma	MYCN non-amp	3	gain	BS_QDMDQ3E3	PASVYV_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_T4KS08ND	32.32
PASKIS	MYCN	Neuroblastoma	MYCN amp	3	gain	BS_QDRHQSPZ	PASKIS_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_6WBAV14H	334.3
PASGGD	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_QKTJ4QY9	PASGGD_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_A2HY1DZA	13.74
PAVKZC	NA	Ganglioneuroblastoma, nodular	MYCN non-amp	NA	NA	BS_QWX24M4X	PAVKZC_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_5Y7PNW71	1.65
PATSUB	MYCN	Neuroblastoma	MYCN non-amp	3	gain	BS_QZAV7XVF	PATSUB_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_NN42N0XB	24.04
PATNWM	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_R0WH31Q0	PATNWM_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_HEKMP7BH	22.37
PASWXG	MYCN	Neuroblastoma	MYCN amp	54	amplification	BS_R13WNSAR	PASWXG_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_GMH5C45K	379.57
PATWIL	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_R66Z3ENM	PATWIL_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_KBXSSXWF	19.1
PASMET	MYCN	Neuroblastoma	MYCN amp	46	amplification	BS_RA5HNMDP	PASMET_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_0SC4QNTM	86.26
PT_BCBMG74N	NA	Neuroblastoma	NA	NA	NA	BS_RECF1S4Q	PT_BCBMG74N_ET_EJ3H8NNB_Not Available_Primary Tumor	ET_EJ3H8NNB	ET_EJ3H8NNB_DGD_COMPT_73	DGD	BS_H9YYADDT	NA
PAUMFN	MYCN	Neuroblastoma	MYCN non-amp	3	gain	BS_RFEDCJTP	PAUMFN_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_WKVJJF3F	33.64
PASTRD	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_RQZZ6T97	PASTRD_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_S01DMJ5X	3.16
PAVAEE	MYCN	Neuroblastoma	MYCN non-amp	3	loss	BS_RR3T675W	PAVAEE_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_323GG6M7	21.04
PATNVA	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_S4R97RNZ	PATNVA_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_KYGRX01W	12.14
PAVJEG	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_S8Q6R8MX	PAVJEG_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_70H191SN	5.13
PATXKN	MYCN	Neuroblastoma	MYCN non-amp	3	gain	BS_SMJRCVQB	PATXKN_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_0D3SCV7P	9.08
PASXWF	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_SPGHWHXY	PASXWF_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_CD6WEHG9	2.17
PASBHS	MYCN	Neuroblastoma	MYCN non-amp	3	gain	BS_SSHQFYA8	PASBHS_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_EF8F5GH8	23.15
PASIUJ	MYCN	Neuroblastoma	MYCN amp	33	amplification	BS_SY6CCX4G	PASIUJ_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_19PXZ71B	149.73
PASCDX	MYCN	Neuroblastoma	MYCN amp	222	amplification	BS_SYSZCYYZ	PASCDX_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_97SKFHM4	181.39
PAUGJI	MYCN	Neuroblastoma	MYCN amp	68	amplification	BS_T5BAS1JN	PAUGJI_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_8MYS5HP4	266.48
PATPPY	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_T9KJYH7M	PATPPY_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_8NQWYZHR	20.82
PASFXC	MYCN	Neuroblastoma	MYCN non-amp	3	gain	BS_T9VPRPVA	PASFXC_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_3KGHX57D	21.59
PASRTR	MYCN	Neuroblastoma	MYCN non-amp	3	gain	BS_TS07B3TC	PASRTR_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_5Z1QJPG6	58.98
PASWMY	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_TT4PHFV7	PASWMY_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_3CTRC269	13
PATDKL	NA	Ganglioneuroblastoma, intermixed	MYCN non-amp	NA	NA	BS_TWN989ZD	PATDKL_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_YF5NCTGA	3.77
PASXHE	MYCN	Neuroblastoma	MYCN non-amp	3	gain	BS_V4VGG98Y	PASXHE_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_EZRVK9ZQ	33.44
PASXHE	MYCN	Neuroblastoma	MYCN non-amp	3	gain	BS_V4VGG98Y	PASXHE_01_Solid Tissue_Primary Tumor	01	01A	GMKF	TARGET-30-PASXHE-01A-01R	74.93
PASLPG	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_V7B79J5R	PASLPG_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_9C595Y9M	8.53
PAUVML	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_VE90VKZY	PAUVML_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_591ZWG14	3.96
PATGIW	NA	Ganglioneuroblastoma, intermixed	MYCN non-amp	NA	NA	BS_VKK21QBZ	PATGIW_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_JBKQ59CW	6.43
PT_CQ9MX63F	NA	Neuroblastoma	Recurrent Neuroblastoma	NA	NA	BS_VV8Q40Y7	PT_CQ9MX63F_ET_2ZJ7FWEY_Solid Tissue_Recurrence	ET_2ZJ7FWEY	ET_2ZJ7FWEY_DGD_COMPT_12	DGD	BS_0X4NPYD3	NA
PATBCM	NA	Ganglioneuroblastoma, nodular	MYCN non-amp	NA	NA	BS_W09W6AAS	PATBCM_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_FE3BY6DT	5.2
PASFIC	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_W22EEJCZ	PASFIC_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_DYHEFXJC	13.49
PASFIC	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_W22EEJCZ	PASFIC_01_Solid Tissue_Primary Tumor	01	01A	GMKF	TARGET-30-PASFIC-01A-01R	33.72
PASKRS	MYCN	Neuroblastoma	MYCN non-amp	3	gain	BS_W41Y820G	PASKRS_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_QS2NKZW3	11.07
PAVJEV	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_WBTZK7A2	PAVJEV_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_HBMHZEGZ	14.22
PAUEXM	MYCN	Neuroblastoma	MYCN non-amp	4	gain	BS_WBZBDN0A	PAUEXM_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_6YYC47K2	40.38
PATIRK	NA	Ganglioneuroblastoma, intermixed	MYCN non-amp	NA	NA	BS_WCEHT7D0	PATIRK_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_NR090DDV	6.42
PATEEE	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_WFZG82XZ	PATEEE_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_XFFQR05Z	8.55
PATLFF	MYCN	Neuroblastoma	MYCN non-amp	3	gain	BS_WRZATZQF	PATLFF_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_JFJYEHFM	18.12
PASEWZ	MYCN	Neuroblastoma	MYCN non-amp	3	gain	BS_X2D8S1HY	PASEWZ_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_8VPBB5C2	36.38
PATSIJ	NA	Ganglioneuroblastoma, nodular	MYCN non-amp	NA	NA	BS_X3AFTRNM	PATSIJ_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_DERH44Z2	19.48
PAVHEU	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_X8H38ZNB	PAVHEU_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_KV05J5BX	6.12
PASDDP	MYCN	Neuroblastoma	MYCN non-amp	3	loss	BS_XA3KEKC6	PASDDP_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_MAJ800Q0	19.57
PATFTR	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_XQC9PNZP	PATFTR_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_GTFHNG3R	27.57
PASYYZ	NA	Ganglioneuroblastoma, intermixed	MYCN non-amp	NA	NA	BS_XQSEQPAZ	PASYYZ_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_EPZ2H50J	1.27
PATDWR	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_XWKDJ2M6	PATDWR_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_4A1CKAXN	15.89
PAVDFW	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_Y3KBY0FY	PAVDFW_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_B2BWSTJV	0.51
PASUFD	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_Y4V9JXG4	PASUFD_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_2XTH5QRD	5.99
PASZRF	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_Y9BHAPG3	PASZRF_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_FRY5NFRY	17.59
PT_K0YFKQ6V	NA	Neuroblastoma	peripheral neuroblastic tumor status post-chemotherapy	NA	NA	BS_YBXM34XV	PT_K0YFKQ6V_7316-7085_Not Available_Initial CNS Tumor	7316-7085	7316-7085_DGD_COMPT_47	DGD	BS_A05MJ45Y	NA
PT_9F58PWB3	MYCN	Neuroblastoma	neuroblastoma	26	amplification	BS_YC4RWPH3	PT_9F58PWB3_7316-3960_Solid Tissue_Progressive	7316-3960	1182252	PBTA	BS_ZJGXGR1V	179.59
PATKGB	MYCN	Neuroblastoma	MYCN non-amp	3	loss	BS_YK9W04XG	PATKGB_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_9BYP1GZS	40.95
PATVRG	MYCN	Neuroblastoma	MYCN non-amp	3	gain	BS_YPKSF86W	PATVRG_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_83RF7CY6	11.96
PAULMT	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_YV3MJ2BD	PAULMT_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_K59AGJKW	13.26
PASAHC	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_Z2G9EG1X	PASAHC_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_AFRGW493	20.59
PARVPD	MYCN	Neuroblastoma	MYCN non-amp	3	gain	BS_Z862V8M7	PARVPD_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_NPVE58AT	12.89
PAUTFT	MYCN	Neuroblastoma	MYCN non-amp	30	amplification	BS_ZED6T1CT	PAUTFT_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_896YFFGE	86.79
PAUFHY	NA	Ganglioneuroblastoma, nodular	MYCN non-amp	NA	NA	BS_ZK0GRMB1	PAUFHY_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_FXDGYFBR	1.54
PAUWHB	NA	Neuroblastoma	MYCN non-amp	NA	NA	BS_ZPXVVM8K	PAUWHB_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_NC4PWRVP	11.54
PASZJB	MYCN	Neuroblastoma	MYCN non-amp	3	loss	BS_ZRG2V7T2	PASZJB_01_Solid Tissue_Primary Tumor	01	01A	GMKF	BS_CXGWN1W5	18.88
PAIFXV	MYCN	Neuroblastoma	MYCN non-amp	3	gain	TARGET-30-PAIFXV-01A-01D	PAIFXV_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PAIFXV-01A-01R	3.17
PAIPGU	MYCN	Neuroblastoma	MYCN non-amp	3	gain	TARGET-30-PAIPGU-01A-01W	PAIPGU_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PAIPGU-01A-01R	17.57
PAITCI	MYCN	Neuroblastoma	MYCN non-amp	2	loss	TARGET-30-PAITCI-01A-01W	PAITCI_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PAITCI-01A-01R	17.43
PAITEG	MYCN	Neuroblastoma	MYCN non-amp	2	neutral	TARGET-30-PAITEG-01A-01W	PAITEG_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PAITEG-01A-01R	1.24
PAIVHE	MYCN	Neuroblastoma	MYCN non-amp	2	loss	TARGET-30-PAIVHE-01A-01W	PAIVHE_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PAIVHE-01A-01R	39.72
PAKYZS	MYCN	Neuroblastoma	MYCN non-amp	2	neutral	TARGET-30-PAKYZS-01A-01W	PAKYZS_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PAKYZS-01A-01R	9.23
PALBFW	MYCN	Neuroblastoma	MYCN non-amp	2	neutral	TARGET-30-PALBFW-01A-01W	PALBFW_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PALBFW-01A-01R	22.9
PALCBW	MYCN	Neuroblastoma	MYCN non-amp	2	loss	TARGET-30-PALCBW-01A-01W	PALCBW_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PALCBW-01A-01R	3.51
PALETP	MYCN	Neuroblastoma	MYCN non-amp	2	neutral	TARGET-30-PALETP-01A-01W	PALETP_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PALETP-01A-01R	35.31
PALEVG	MYCN	Neuroblastoma	MYCN amp	44	amplification	TARGET-30-PALEVG-01A-01W	PALEVG_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PALEVG-01A-01R	732.82
PALIIN	MYCN	Neuroblastoma	MYCN non-amp	2	loss	TARGET-30-PALIIN-01A-01W	PALIIN_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PALIIN-01A-01R	55.37
PALTEG	MYCN	Neuroblastoma	MYCN non-amp	2	neutral	TARGET-30-PALTEG-01A-01W	PALTEG_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PALTEG-01A-01R	17.22
PALWVJ	MYCN	Neuroblastoma	MYCN non-amp	2	neutral	TARGET-30-PALWVJ-01A-01W	PALWVJ_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PALWVJ-01A-01R	8.86
PALZZV	MYCN	Neuroblastoma	MYCN amp	86	amplification	TARGET-30-PALZZV-01A-01W	PALZZV_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PALZZV-01A-01R	818.77
PAMMXF	MYCN	Neuroblastoma	MYCN amp	2	neutral	TARGET-30-PAMMXF-01A-01W	PAMMXF_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PAMMXF-01A-01R	482.57
PAMVRA	MYCN	Ganglioneuroblastoma, nodular	MYCN non-amp	2	loss	TARGET-30-PAMVRA-01A-01W	PAMVRA_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PAMVRA-01A-01R	57.44
PAMYCE	MYCN	Neuroblastoma	MYCN non-amp	2	loss	TARGET-30-PAMYCE-01A-01W	PAMYCE_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PAMYCE-01A-01R	24.37
PAMZGT	MYCN	Neuroblastoma	MYCN amp	23	amplification	TARGET-30-PAMZGT-01A-01W	PAMZGT_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PAMZGT-01A-01R	214.79
PAMZMG	MYCN	Neuroblastoma	MYCN amp	44	amplification	TARGET-30-PAMZMG-01A-01W	PAMZMG_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PAMZMG-01A-01R	594.01
PANBMJ	MYCN	Ganglioneuroblastoma, nodular	MYCN non-amp	2	neutral	TARGET-30-PANBMJ-01A-01W	PANBMJ_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PANBMJ-01A-01R	3.53
PANBSP	MYCN	Neuroblastoma	MYCN non-amp	3	neutral	TARGET-30-PANBSP-01A-01W	PANBSP_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PANBSP-01A-01R	45.6
PANKFE	MYCN	Neuroblastoma	MYCN non-amp	2	neutral	TARGET-30-PANKFE-01A-01W	PANKFE_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PANKFE-01A-01R	4.39
PANLET	MYCN	Ganglioneuroblastoma, nodular	MYCN non-amp	2	loss	TARGET-30-PANLET-01A-01D	PANLET_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PANLET-01A-01R	31.45
PANRHJ	MYCN	Neuroblastoma	MYCN non-amp	2	neutral	TARGET-30-PANRHJ-01A-01W	PANRHJ_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PANRHJ-01A-01R	22.58
PANRVJ	MYCN	Neuroblastoma	MYCN non-amp	2	loss	TARGET-30-PANRVJ-01A-01D	PANRVJ_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PANRVJ-01A-01R	26.77
PANSBN	MYCN	Ganglioneuroblastoma, nodular	MYCN non-amp	2	neutral	TARGET-30-PANSBN-01A-01D	PANSBN_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PANSBN-01A-01R	0.64
PANUIF	MYCN	Neuroblastoma	MYCN non-amp	3	gain	TARGET-30-PANUIF-01A-01D	PANUIF_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PANUIF-01A-01R	11.99
PANWRR	MYCN	Neuroblastoma	MYCN non-amp	2	neutral	TARGET-30-PANWRR-01A-01D	PANWRR_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PANWRR-01A-01R	40.86
PANXJL	MYCN	Ganglioneuroblastoma, nodular	MYCN non-amp	2	loss	TARGET-30-PANXJL-01A-01D	PANXJL_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PANXJL-01A-01R	1.55
PANYGR	MYCN	Neuroblastoma	MYCN non-amp	2	loss	TARGET-30-PANYGR-01A-01W	PANYGR_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PANYGR-01A-01R	30.92
PANZPV	MYCN	Neuroblastoma	MYCN non-amp	2	loss	TARGET-30-PANZPV-01A-01W	PANZPV_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PANZPV-01A-01R	12.01
PANZVU	MYCN	Neuroblastoma	MYCN non-amp	2	loss	TARGET-30-PANZVU-01A-01W	PANZVU_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PANZVU-01A-01R	37.11
PAPBGH	MYCN	Neuroblastoma	MYCN non-amp	2	loss	TARGET-30-PAPBGH-01A-01W	PAPBGH_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PAPBGH-01A-01R	0.47
PAPBJE	MYCN	Neuroblastoma	MYCN amp	216	amplification	TARGET-30-PAPBJE-01A-01D	PAPBJE_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PAPBJE-01A-01R	703.67
PAPBZI	MYCN	Neuroblastoma	MYCN non-amp	4	gain	TARGET-30-PAPBZI-01A-01W	PAPBZI_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PAPBZI-01A-01R	22.34
PAPCTS	MYCN	Neuroblastoma	MYCN amp	129	amplification	TARGET-30-PAPCTS-01A-01D	PAPCTS_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PAPCTS-01A-01R	1530.68
PAPEFE	MYCN	Neuroblastoma	MYCN amp	7	amplification	TARGET-30-PAPEFE-01A-01W	PAPEFE_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PAPEFE-01A-01R	235.04
PAPHPE	MYCN	Neuroblastoma	MYCN non-amp	3	neutral	TARGET-30-PAPHPE-01A-01W	PAPHPE_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PAPHPE-01A-01R	6.12
PAPKWN	MYCN	Neuroblastoma	MYCN amp	13	amplification	TARGET-30-PAPKWN-01A-01W	PAPKWN_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PAPKWN-01A-01R	51.31
PAPKXS	MYCN	Neuroblastoma	MYCN non-amp	3	gain	TARGET-30-PAPKXS-01A-01D	PAPKXS_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PAPKXS-01A-01R	138.23
PAPLSD	MYCN	Neuroblastoma	MYCN non-amp	3	gain	TARGET-30-PAPLSD-01A-01D	PAPLSD_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PAPLSD-01A-01R	22.99
PAPTAN	MYCN	Ganglioneuroblastoma, nodular	MYCN non-amp	2	neutral	TARGET-30-PAPTAN-01A-01D	PAPTAN_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PAPTAN-01A-01R	16.17
PAPTCR	MYCN	Neuroblastoma	NA	2	neutral	TARGET-30-PAPTCR-01A-01D	PAPTCR_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PAPTCR-01A-01R	5.71
PAPTFZ	MYCN	Neuroblastoma	MYCN amp	125	amplification	TARGET-30-PAPTFZ-01A-01D	PAPTFZ_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PAPTFZ-01A-01R	841.05
PAPTLV	MYCN	Neuroblastoma	MYCN amp	24	amplification	TARGET-30-PAPTLV-01A-01D	PAPTLV_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PAPTLV-01A-01R	255.44
PAPUWY	MYCN	Neuroblastoma	MYCN non-amp	2	loss	TARGET-30-PAPUWY-01A-01D	PAPUWY_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PAPUWY-01A-01R	48.51
PAPVFD	MYCN	Neuroblastoma	MYCN non-amp	2	loss	TARGET-30-PAPVFD-01A-01D	PAPVFD_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PAPVFD-01A-01R	76.15
PAPVRN	MYCN	Ganglioneuroblastoma, nodular	MYCN non-amp	2	loss	TARGET-30-PAPVRN-01A-01D	PAPVRN_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PAPVRN-01A-01R	6.59
PAPVXS	MYCN	Neuroblastoma	MYCN non-amp	3	neutral	TARGET-30-PAPVXS-01A-01D	PAPVXS_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PAPVXS-01A-01R	36.95
PAPZYZ	MYCN	Neuroblastoma	MYCN amp	131	amplification	TARGET-30-PAPZYZ-01A-01D	PAPZYZ_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PAPZYZ-01A-01R	273.22
PARACS	MYCN	Neuroblastoma	MYCN non-amp	3	neutral	TARGET-30-PARACS-01A-01D	PARACS_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PARACS-01A-01R	36.69
PARAMT	MYCN	Ganglioneuroblastoma, nodular	MYCN non-amp	3	neutral	TARGET-30-PARAMT-01A-01D	PARAMT_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PARAMT-01A-01R	73.4
PARBGP	MYCN	Neuroblastoma	MYCN non-amp	2	loss	TARGET-30-PARBGP-01A-01D	PARBGP_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PARBGP-01A-01R	59.05
PARDCK	MYCN	Ganglioneuroblastoma, nodular	MYCN non-amp	2	loss	TARGET-30-PARDCK-01A-01D	PARDCK_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PARDCK-01A-01R	8.07
PARDIW	MYCN	Neuroblastoma	MYCN non-amp	2	loss	TARGET-30-PARDIW-01A-01D	PARDIW_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PARDIW-01A-01R	22.26
PARFWB	MYCN	Neuroblastoma	MYCN non-amp	2	neutral	TARGET-30-PARFWB-01A-01D	PARFWB_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PARFWB-01A-01R	34.21
PARGKK	MYCN	Neuroblastoma	MYCN non-amp	2	neutral	TARGET-30-PARGKK-01A-01D	PARGKK_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PARGKK-01A-01R	32.9
PARKGJ	MYCN	Neuroblastoma	MYCN non-amp	3	gain	TARGET-30-PARKGJ-01A-01D	PARKGJ_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PARKGJ-01A-01R	10.02
PARSBI	MYCN	Neuroblastoma	MYCN non-amp	2	loss	TARGET-30-PARSBI-01A-01D	PARSBI_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PARSBI-01A-01R	13.29
PARTRP	NA	Neuroblastoma	MYCN non-amp	NA	NA	TARGET-30-PARTRP-01A-01D	PARTRP_01_Solid Tissue_Primary Tumor	01	01A	TARGET	BS_S0B4WASX	16.43
PARUTJ	NA	Neuroblastoma	MYCN non-amp	NA	NA	TARGET-30-PARUTJ-01A-01D	PARUTJ_01_Solid Tissue_Primary Tumor	01	01A	TARGET	BS_S5KDWVEA	0.41
PARVLK	MYCN	Ganglioneuroblastoma, intermixed	MYCN non-amp	2	loss	TARGET-30-PARVLK-01A-01D	PARVLK_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PARVLK-01A-01R	11.15
PARWEV	NA	Neuroblastoma	MYCN non-amp	NA	NA	TARGET-30-PARWEV-01A-01D	PARWEV_01_Solid Tissue_Primary Tumor	01	01A	TARGET	BS_DBXCETW2	33.86
PARXPD	NA	Neuroblastoma	MYCN non-amp	NA	NA	TARGET-30-PARXPD-01A-01D	PARXPD_01_Solid Tissue_Primary Tumor	01	01A	TARGET	BS_3N0ZS3G3	24.86
PARYEH	NA	Neuroblastoma	MYCN non-amp	NA	NA	TARGET-30-PARYEH-01A-01D	PARYEH_01_Solid Tissue_Primary Tumor	01	01A	TARGET	BS_2Y28PRQC	22.31
PARYNK	MYCN	Neuroblastoma	MYCN non-amp	2	neutral	TARGET-30-PARYNK-01A-01D	PARYNK_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PARYNK-01A-01R	5.63
PARYRJ	NA	Neuroblastoma	MYCN non-amp	NA	NA	TARGET-30-PARYRJ-01A-01D	PARYRJ_01_Solid Tissue_Primary Tumor	01	01A	TARGET	BS_JY850J9G	26.4
PARZBH	NA	Neuroblastoma	MYCN non-amp	NA	NA	TARGET-30-PARZBH-01A-01D	PARZBH_01_Solid Tissue_Primary Tumor	01	01A	TARGET	BS_BG0ZDND2	22.7
PARZIP	MYCN	Neuroblastoma	MYCN non-amp	3	loss	TARGET-30-PARZIP-01A-01D	PARZIP_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PARZIP-01A-01R	53.23
PASAHC	NA	Neuroblastoma	MYCN non-amp	NA	NA	TARGET-30-PASAHC-01A-01D	PASAHC_01_Solid Tissue_Primary Tumor	01	01A	TARGET	BS_AFRGW493	20.59
PASAVJ	NA	Neuroblastoma	MYCN non-amp	NA	NA	TARGET-30-PASAVJ-01A-01D	PASAVJ_01_Solid Tissue_Primary Tumor	01	01A	TARGET	BS_28ZRHXX8	21.16
PASBDN	NA	Neuroblastoma	MYCN non-amp	NA	NA	TARGET-30-PASBDN-01A-01D	PASBDN_01_Solid Tissue_Primary Tumor	01	01A	TARGET	BS_15ED4VDX	31.15
PASCDX	MYCN	Neuroblastoma	MYCN amp	106	amplification	TARGET-30-PASCDX-01A-01D	PASCDX_01_Solid Tissue_Primary Tumor	01	01A	TARGET	BS_97SKFHM4	181.39
PASCWD	NA	Neuroblastoma	MYCN amp	NA	NA	TARGET-30-PASCWD-01A-01D	PASCWD_01_Solid Tissue_Primary Tumor	01	01A	TARGET	BS_W5X4568N	310.39
PASDDP	NA	Neuroblastoma	MYCN non-amp	NA	NA	TARGET-30-PASDDP-01A-01D	PASDDP_01_Solid Tissue_Primary Tumor	01	01A	TARGET	BS_MAJ800Q0	19.57
PASDYT	NA	Neuroblastoma	MYCN non-amp	NA	NA	TARGET-30-PASDYT-01A-01D	PASDYT_01_Solid Tissue_Primary Tumor	01	01A	TARGET	BS_N13KZYRR	17.46
PASEGA	MYCN	Ganglioneuroblastoma, nodular	MYCN non-amp	2	neutral	TARGET-30-PASEGA-01A-01D	PASEGA_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PASEGA-01A-01R	16.44
PASEWZ	NA	Neuroblastoma	MYCN non-amp	NA	NA	TARGET-30-PASEWZ-01A-01D	PASEWZ_01_Solid Tissue_Primary Tumor	01	01A	TARGET	BS_8VPBB5C2	36.38
PASFCG	NA	Neuroblastoma	MYCN non-amp	NA	NA	TARGET-30-PASFCG-01A-01D	PASFCG_01_Solid Tissue_Primary Tumor	01	01A	TARGET	BS_WR5VE59B	24.8
PASFEV	NA	Neuroblastoma	MYCN non-amp	NA	NA	TARGET-30-PASFEV-01A-01D	PASFEV_01_Solid Tissue_Primary Tumor	01	01A	TARGET	BS_Z0MTZA9K	32.76
PASFGG	MYCN	Neuroblastoma	MYCN non-amp	2	neutral	TARGET-30-PASFGG-01A-01D	PASFGG_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PASFGG-01A-01R	18.94
PASFKX	NA	Neuroblastoma	MYCN amp	NA	NA	TARGET-30-PASFKX-01A-01D	PASFKX_01_Solid Tissue_Primary Tumor	01	01A	TARGET	BS_6N7RPHX9	392.43
PASFWL	NA	Neuroblastoma	MYCN non-amp	NA	NA	TARGET-30-PASFWL-01A-01D	PASFWL_01_Solid Tissue_Primary Tumor	01	01A	TARGET	BS_WHX83JW2	34.59
PASFXC	NA	Neuroblastoma	MYCN non-amp	NA	NA	TARGET-30-PASFXC-01A-01D	PASFXC_01_Solid Tissue_Primary Tumor	01	01A	TARGET	BS_3KGHX57D	21.59
PASGAP	MYCN	Ganglioneuroblastoma, nodular	MYCN non-amp	2	loss	TARGET-30-PASGAP-01A-01D	PASGAP_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PASGAP-01A-01R	5.34
PASGUT	MYCN	Ganglioneuroblastoma, nodular	MYCN non-amp	2	loss	TARGET-30-PASGUT-01A-01D	PASGUT_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PASGUT-01A-01R	22.29
PASJTA	NA	Neuroblastoma	MYCN non-amp	NA	NA	TARGET-30-PASJTA-01A-01D	PASJTA_01_Solid Tissue_Primary Tumor	01	01A	TARGET	BS_WHBM0N3Y	19.87
PASKRS	NA	Neuroblastoma	MYCN non-amp	NA	NA	TARGET-30-PASKRS-01A-01D	PASKRS_01_Solid Tissue_Primary Tumor	01	01A	TARGET	BS_QS2NKZW3	11.07
PASKZT	NA	Neuroblastoma	MYCN non-amp	NA	NA	TARGET-30-PASKZT-01A-01D	PASKZT_01_Solid Tissue_Primary Tumor	01	01A	TARGET	BS_CZ7DWCPE	2.05
PASLIH	NA	Neuroblastoma	MYCN non-amp	NA	NA	TARGET-30-PASLIH-01A-01D	PASLIH_01_Solid Tissue_Primary Tumor	01	01A	TARGET	BS_HW9CGZ29	20.29
PASLPG	NA	Neuroblastoma	MYCN non-amp	NA	NA	TARGET-30-PASLPG-01A-01D	PASLPG_01_Solid Tissue_Primary Tumor	01	01A	TARGET	BS_9C595Y9M	8.53
PASLTC	NA	Neuroblastoma	MYCN non-amp	NA	NA	TARGET-30-PASLTC-01A-01D	PASLTC_01_Solid Tissue_Primary Tumor	01	01A	TARGET	BS_ZWRZRC4V	48.71
PASMET	NA	Neuroblastoma	MYCN amp	NA	NA	TARGET-30-PASMET-01A-01D	PASMET_01_Solid Tissue_Primary Tumor	01	01A	TARGET	BS_0SC4QNTM	86.26
PASMJG	MYCN	Ganglioneuroblastoma, nodular	MYCN non-amp	2	neutral	TARGET-30-PASMJG-01A-01D	PASMJG_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PASMJG-01A-01R	1.73
PASMNT	MYCN	Neuroblastoma	MYCN non-amp	2	neutral	TARGET-30-PASMNT-01A-01D	PASMNT_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PASMNT-01A-01R	46.44
PASMUB	NA	Neuroblastoma	MYCN non-amp	NA	NA	TARGET-30-PASMUB-01A-01D	PASMUB_01_Solid Tissue_Primary Tumor	01	01A	TARGET	BS_H5RWQDCJ	10.97
PASNEF	MYCN	Neuroblastoma	MYCN non-amp	2	loss	TARGET-30-PASNEF-01A-01D	PASNEF_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PASNEF-01A-01R	33.26
PASNUI	NA	Neuroblastoma	MYCN amp	NA	NA	TARGET-30-PASNUI-01A-01D	PASNUI_01_Solid Tissue_Primary Tumor	01	01A	TARGET	BS_3CSY3JTN	407.97
PASNZU	MYCN	Neuroblastoma	MYCN amp	152	amplification	TARGET-30-PASNZU-01A-01D	PASNZU_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PASNZU-01A-01R	1052.53
PASPER	MYCN	Neuroblastoma	MYCN non-amp	2	neutral	TARGET-30-PASPER-01A-01D	PASPER_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PASPER-01A-01R	14.89
PASPGB	NA	Neuroblastoma	MYCN amp	NA	NA	TARGET-30-PASPGB-01A-01D	PASPGB_01_Solid Tissue_Primary Tumor	01	01A	TARGET	BS_94ZKC2SR	273.35
PASRFS	MYCN	Neuroblastoma	MYCN non-amp	2	neutral	TARGET-30-PASRFS-01A-01D	PASRFS_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PASRFS-01A-01R	45.74
PASSRN	MYCN	Neuroblastoma	MYCN amp	522	amplification	TARGET-30-PASSRN-01A-01D	PASSRN_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PASSRN-01A-01R	738.94
PASSRS	MYCN	Neuroblastoma	MYCN non-amp	2	loss	TARGET-30-PASSRS-01A-01D	PASSRS_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PASSRS-01A-01R	18.08
PASTCN	MYCN	Neuroblastoma	MYCN non-amp	2	loss	TARGET-30-PASTCN-01A-01D	PASTCN_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PASTCN-01A-01R	36.66
PASTKC	MYCN	Neuroblastoma	MYCN non-amp	2	loss	TARGET-30-PASTKC-01A-01D	PASTKC_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PASTKC-01A-01R	24.11
PASTWY	NA	Neuroblastoma	MYCN non-amp	NA	NA	TARGET-30-PASTWY-01A-01D	PASTWY_01_Solid Tissue_Primary Tumor	01	01A	TARGET	BS_8EX2H96N	42.87
PASUCB	MYCN	Neuroblastoma	MYCN non-amp	2	loss	TARGET-30-PASUCB-01A-01D	PASUCB_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PASUCB-01A-01R	11.22
PASUCU	NA	Neuroblastoma	MYCN non-amp	NA	NA	TARGET-30-PASUCU-01A-01D	PASUCU_01_Solid Tissue_Primary Tumor	01	01A	TARGET	BS_4JVC08W2	26.41
PASUEZ	NA	Neuroblastoma	MYCN non-amp	NA	NA	TARGET-30-PASUEZ-01A-01D	PASUEZ_01_Solid Tissue_Primary Tumor	01	01A	TARGET	BS_MDEQHB6J	33.28
PASUYG	MYCN	Neuroblastoma	MYCN non-amp	3	neutral	TARGET-30-PASUYG-01A-01D	PASUYG_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PASUYG-01A-01R	7.84
PASVRU	MYCN	Neuroblastoma	MYCN amp	121	amplification	TARGET-30-PASVRU-01A-01D	PASVRU_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PASVRU-01A-01R	473.38
PASVYV	NA	Neuroblastoma	MYCN non-amp	NA	NA	TARGET-30-PASVYV-01A-01D	PASVYV_01_Solid Tissue_Primary Tumor	01	01A	TARGET	BS_T4KS08ND	32.32
PASWFB	MYCN	Neuroblastoma	MYCN amp	195	amplification	TARGET-30-PASWFB-01A-01D	PASWFB_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PASWFB-01A-01R	1034.06
PASWIJ	MYCN	Neuroblastoma	MYCN non-amp	3	neutral	TARGET-30-PASWIJ-01A-01D	PASWIJ_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PASWIJ-01A-01R	57.63
PASWVY	MYCN	Ganglioneuroblastoma, nodular	MYCN non-amp	4	gain	TARGET-30-PASWVY-01A-01D	PASWVY_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PASWVY-01A-01R	77.32
PASWXG	NA	Neuroblastoma	MYCN amp	NA	NA	TARGET-30-PASWXG-01A-01D	PASWXG_01_Solid Tissue_Primary Tumor	01	01A	TARGET	BS_GMH5C45K	379.57
PASWYR	MYCN	Neuroblastoma	MYCN amp	138	amplification	TARGET-30-PASWYR-01A-01D	PASWYR_01_Solid Tissue_Primary Tumor	01	01A	TARGET	BS_MPE34NYZ	368.45
PASWYR	MYCN	Neuroblastoma	MYCN amp	138	amplification	TARGET-30-PASWYR-01A-01D	PASWYR_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PASWYR-01A-01R	1027.81
PASXGP	MYCN	Ganglioneuroblastoma, nodular	MYCN non-amp	2	neutral	TARGET-30-PASXGP-01A-01D	PASXGP_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PASXGP-01A-01R	53.89
PASXHE	MYCN	Neuroblastoma	MYCN non-amp	3	gain	TARGET-30-PASXHE-01A-01D	PASXHE_01_Solid Tissue_Primary Tumor	01	01A	TARGET	BS_EZRVK9ZQ	33.44
PASXHE	MYCN	Neuroblastoma	MYCN non-amp	3	gain	TARGET-30-PASXHE-01A-01D	PASXHE_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PASXHE-01A-01R	74.93
PASXRG	MYCN	Ganglioneuroblastoma, nodular	MYCN amp	14	amplification	TARGET-30-PASXRG-01A-01D	PASXRG_01_Solid Tissue_Primary Tumor	01	01A	TARGET	BS_9JBYGRQW	181.71
PASXRG	MYCN	Ganglioneuroblastoma, nodular	MYCN amp	14	amplification	TARGET-30-PASXRG-01A-01D	PASXRG_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PASXRG-01A-01R	285.66
PASXRJ	MYCN	Neuroblastoma	MYCN non-amp	2	neutral	TARGET-30-PASXRJ-01A-01D	PASXRJ_01_Solid Tissue_Primary Tumor	01	01A	TARGET	BS_1BKHK7AY	14.24
PASXRJ	MYCN	Neuroblastoma	MYCN non-amp	2	neutral	TARGET-30-PASXRJ-01A-01D	PASXRJ_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PASXRJ-01A-01R	34.46
PASYPX	MYCN	Neuroblastoma	MYCN non-amp	3	neutral	TARGET-30-PASYPX-01A-01D	PASYPX_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PASYPX-01A-01R	31.64
PASZJB	NA	Neuroblastoma	MYCN non-amp	NA	NA	TARGET-30-PASZJB-01A-01D	PASZJB_01_Solid Tissue_Primary Tumor	01	01A	TARGET	BS_CXGWN1W5	18.88
PASZPI	MYCN	Neuroblastoma	MYCN amp	44	amplification	TARGET-30-PASZPI-01A-01D	PASZPI_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PASZPI-01A-01R	894.63
PATAAV	NA	Neuroblastoma	MYCN non-amp	NA	NA	TARGET-30-PATAAV-01A-01D	PATAAV_01_Solid Tissue_Primary Tumor	01	01A	TARGET	BS_XJDB3R9K	8.73
PATBHY	NA	Neuroblastoma	MYCN non-amp	NA	NA	TARGET-30-PATBHY-01A-01D	PATBHY_01_Solid Tissue_Primary Tumor	01	01A	TARGET	BS_NQP7B1SY	16.32
PATBMM	MYCN	Ganglioneuroblastoma, nodular	MYCN non-amp	2	loss	TARGET-30-PATBMM-01A-01D	PATBMM_01_Solid Tissue_Primary Tumor	01	01A	TARGET	BS_3DJBSNGE	12.3
PATBMM	MYCN	Ganglioneuroblastoma, nodular	MYCN non-amp	2	loss	TARGET-30-PATBMM-01A-01D	PATBMM_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PATBMM-01A-01R	15.49
PATCFL	MYCN	Neuroblastoma	MYCN non-amp	2	neutral	TARGET-30-PATCFL-01A-01D	PATCFL_01_Solid Tissue_Primary Tumor	01	01A	TARGET	BS_N05R3CT2	3.24
PATCFL	MYCN	Neuroblastoma	MYCN non-amp	2	neutral	TARGET-30-PATCFL-01A-01D	PATCFL_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PATCFL-01A-01R	6.9
PATDCJ	NA	Neuroblastoma	MYCN non-amp	NA	NA	TARGET-30-PATDCJ-01A-01D	PATDCJ_01_Solid Tissue_Primary Tumor	01	01A	TARGET	BS_BBD7XS5N	13.3
PATDWN	MYCN	Neuroblastoma	MYCN amp	238	amplification	TARGET-30-PATDWN-01A-01D	PATDWN_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PATDWN-01A-01R	1540.66
PATDXC	MYCN	Neuroblastoma	MYCN non-amp	3	neutral	TARGET-30-PATDXC-01A-01D	PATDXC_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PATDXC-01A-01R	58.6
PATDXG	MYCN	Neuroblastoma	MYCN amp	118	amplification	TARGET-30-PATDXG-01A-01D	PATDXG_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PATDXG-01A-01R	1449.04
PATEKG	MYCN	Ganglioneuroblastoma, nodular	MYCN non-amp	2	neutral	TARGET-30-PATEKG-01A-01D	PATEKG_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PATEKG-01A-01R	5.33
PATEPF	MYCN	Ganglioneuroblastoma, nodular	MYCN non-amp	2	neutral	TARGET-30-PATEPF-01A-01D	PATEPF_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PATEPF-01A-01R	40.48
PATESI	MYCN	Neuroblastoma	MYCN amp	105	amplification	TARGET-30-PATESI-01A-01D	PATESI_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PATESI-01A-01R	1278.85
PATFCY	MYCN	Neuroblastoma	MYCN non-amp	2	loss	TARGET-30-PATFCY-01A-01D	PATFCY_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PATFCY-01A-01R	60.56
PATFTR	NA	Neuroblastoma	MYCN non-amp	NA	NA	TARGET-30-PATFTR-01A-01D	PATFTR_01_Solid Tissue_Primary Tumor	01	01A	TARGET	BS_GTFHNG3R	27.57
PATFXV	MYCN	Neuroblastoma	MYCN amp	188	amplification	TARGET-30-PATFXV-01A-01D	PATFXV_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PATFXV-01A-01R	1554.55
PATGLU	MYCN	Neuroblastoma	MYCN non-amp	3	gain	TARGET-30-PATGLU-01A-01D	PATGLU_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PATGLU-01A-01R	50.36
PATHVK	MYCN	Neuroblastoma	MYCN non-amp	4	neutral	TARGET-30-PATHVK-01A-01D	PATHVK_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PATHVK-01A-01R	25.72
PATINJ	MYCN	Neuroblastoma	MYCN non-amp	2	neutral	TARGET-30-PATINJ-01A-01D	PATINJ_01_Solid Tissue_Primary Tumor	01	01A	TARGET	TARGET-30-PATINJ-01A-01R	52.26
PATKGB	NA	Neuroblastoma	MYCN non-amp	NA	NA	TARGET-30-PATKGB-01A-01D	PATKGB_01_Solid Tissue_Primary Tumor	01	01A	TARGET	BS_9BYP1GZS	40.95
PATLKI	NA	Ganglioneuroblastoma, nodular	MYCN amp	NA	NA	TARGET-30-PATLKI-01A-01D	PATLKI_01_Solid Tissue_Primary Tumor	01	01A	TARGET	BS_QJ3XB7XZ	29.28
PATNXK	NA	Neuroblastoma	MYCN non-amp	NA	NA	TARGET-30-PATNXK-01A-01D	PATNXK_01_Solid Tissue_Primary Tumor	01	01A	TARGET	BS_S0SM38BZ	23.59
PATTPC	NA	Neuroblastoma	MYCN amp	NA	NA	TARGET-30-PATTPC-01A-01D	PATTPC_01_Solid Tissue_Primary Tumor	01	01A	TARGET	BS_NKGRBE18	393.89
PATWED	NA	Neuroblastoma	MYCN amp	NA	NA	TARGET-30-PATWED-01A-01D	PATWED_01_Solid Tissue_Primary Tumor	01	01A	TARGET	BS_YA56YE71	82.09
PATWIL	NA	Neuroblastoma	MYCN non-amp	NA	NA	TARGET-30-PATWIL-01A-01D	PATWIL_01_Solid Tissue_Primary Tumor	01	01A	TARGET	BS_KBXSSXWF	19.1
PATXTF	NA	Neuroblastoma	MYCN non-amp	NA	NA	TARGET-30-PATXTF-01A-01D	PATXTF_01_Solid Tissue_Primary Tumor	01	01A	TARGET	BS_BW9QBKEQ	36.56
PATZRF	NA	Neuroblastoma	MYCN amp	NA	NA	TARGET-30-PATZRF-01A-01D	PATZRF_01_Solid Tissue_Primary Tumor	01	01A	TARGET	BS_S4WH99C9	235.02
PAUCRL	NA	Ganglioneuroblastoma, nodular	MYCN non-amp	NA	NA	TARGET-30-PAUCRL-01A-01D	PAUCRL_01_Solid Tissue_Primary Tumor	01	01A	TARGET	BS_SM1QE9FJ	10.42
PAUGJI	NA	Neuroblastoma	MYCN amp	NA	NA	TARGET-30-PAUGJI-01A-01D	PAUGJI_01_Solid Tissue_Primary Tumor	01	01A	TARGET	BS_8MYS5HP4	266.48
PAUGVZ	NA	Neuroblastoma	MYCN non-amp	NA	NA	TARGET-30-PAUGVZ-01A-01D	PAUGVZ_01_Solid Tissue_Primary Tumor	01	01A	TARGET	BS_J9EH31NM	15.43
PAUJRW	NA	Neuroblastoma	MYCN amp	NA	NA	TARGET-30-PAUJRW-01A-01D	PAUJRW_01_Solid Tissue_Primary Tumor	01	01A	TARGET	BS_ZFJS669M	352.32
PAUJTY	NA	Neuroblastoma	MYCN non-amp	NA	NA	TARGET-30-PAUJTY-01A-01D	PAUJTY_01_Solid Tissue_Primary Tumor	01	01A	TARGET	BS_X3F8NMS4	14.62
PAUKLK	NA	Neuroblastoma	MYCN amp	NA	NA	TARGET-30-PAUKLK-01A-01D	PAUKLK_01_Solid Tissue_Primary Tumor	01	01A	TARGET	BS_94JMQ7MX	296.15
PAULMT	NA	Neuroblastoma	MYCN non-amp	NA	NA	TARGET-30-PAULMT-01A-01D	PAULMT_01_Solid Tissue_Primary Tumor	01	01A	TARGET	BS_K59AGJKW	13.26
PAUNTY	NA	Neuroblastoma	MYCN amp	NA	NA	TARGET-30-PAUNTY-01A-01D	PAUNTY_01_Solid Tissue_Primary Tumor	01	01A	TARGET	BS_VNKT3ZZS	312.62
PAUSJB	NA	Neuroblastoma	MYCN non-amp	NA	NA	TARGET-30-PAUSJB-01A-01D	PAUSJB_01_Solid Tissue_Primary Tumor	01	01A	TARGET	BS_GB1XPW06	8.68
PAVALS	NA	Neuroblastoma	MYCN non-amp	NA	NA	TARGET-30-PAVALS-01A-01D	PAVALS_01_Solid Tissue_Primary Tumor	01	01A	TARGET	BS_NZDEF29S	30.63
